Overcoming mutagenicity and ion channel activity: optimization of selective spleen tyrosine kinase inhibitors.
暂无分享，去创建一个
Matthew L. Maddess | H. Houshyar | M. Altman | S. Galloway | A. Bass | Nancy Kelly | J. W. Butcher | James P. Jewell | Anthony E Donofrio | J. Miller | Ryan Otte | S. Vincent | Binyuan Sun | Alan B. Northrup | L. Moy | G. Ward | Sandra Lee | A. Byford | Chiming Yang | J. M. Ellis | Ekundayo Osimboni | Kerrie B. Spencer | M. V. Reddy | Andrew M Haidle | Erica K Leccese | Grace H C Woo